- Home
- PLSE vs RLAY Comparison
PLSE vs RLAY Comparison
Compare PLSE & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | RLAY |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.1B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PLSE | RLAY |
|---|---|---|
| Price | $52.82 | $18.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $56.50 | $27.58 |
| AVG Volume (30 Days) | 483.5K | ★ 3.0M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $477.71 | N/A |
| Revenue Next Year | $233.00 | $60.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $12.56 | $5.85 |
| 52 Week High | $58.90 | $21.27 |
Technical Indicators
Market Signals| Indicator | PLSE | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 57.23 | 46.12 |
| Support Level | $49.01 | $17.83 |
| Resistance Level | $57.82 | $20.54 |
| Average True Range (ATR) | 2.79 | 1.02 |
| MACD | -0.36 | -0.02 |
| Stochastic Oscillator | 58.11 | 44.68 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.